DE69502168D1 - Lactone mit antioxidativer und hypolipidaemischer Wirkung zur Behandlung von Atherosklerose - Google Patents

Lactone mit antioxidativer und hypolipidaemischer Wirkung zur Behandlung von Atherosklerose

Info

Publication number
DE69502168D1
DE69502168D1 DE69502168T DE69502168T DE69502168D1 DE 69502168 D1 DE69502168 D1 DE 69502168D1 DE 69502168 T DE69502168 T DE 69502168T DE 69502168 T DE69502168 T DE 69502168T DE 69502168 D1 DE69502168 D1 DE 69502168D1
Authority
DE
Germany
Prior art keywords
atherosclerosis
lactones
treatment
antioxidant
lipoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69502168T
Other languages
English (en)
Other versions
DE69502168T2 (de
Inventor
Goffredo Rosini
Claudia Baldazzi
Eleonora Romagnoli
Stefano Saguatti
Silvano Piani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wasserman SpA
Original Assignee
Alfa Wasserman SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wasserman SpA filed Critical Alfa Wasserman SpA
Application granted granted Critical
Publication of DE69502168D1 publication Critical patent/DE69502168D1/de
Publication of DE69502168T2 publication Critical patent/DE69502168T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DE69502168T 1994-12-21 1995-11-27 Lactone mit antioxidativer und hypolipidaemischer Wirkung zur Behandlung von Atherosklerose Expired - Fee Related DE69502168T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Publications (2)

Publication Number Publication Date
DE69502168D1 true DE69502168D1 (de) 1998-05-28
DE69502168T2 DE69502168T2 (de) 1998-08-13

Family

ID=11340165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69502168T Expired - Fee Related DE69502168T2 (de) 1994-12-21 1995-11-27 Lactone mit antioxidativer und hypolipidaemischer Wirkung zur Behandlung von Atherosklerose

Country Status (9)

Country Link
US (1) US5608084A (de)
EP (1) EP0718295B1 (de)
JP (1) JP2820652B2 (de)
AT (1) ATE165354T1 (de)
DE (1) DE69502168T2 (de)
DK (1) DK0718295T3 (de)
ES (1) ES2115308T3 (de)
GR (1) GR3026702T3 (de)
IT (1) IT1274355B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680340B2 (en) * 2000-08-21 2004-01-20 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
DE10261067A1 (de) * 2002-12-24 2004-08-05 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4665091A (en) * 1985-11-04 1987-05-12 Merck & Co., Inc. Macrocyclic lactone HMG-CoA reductase inhibitors
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
US5608084A (en) 1997-03-04
ITBO940562A0 (it) 1994-12-21
EP0718295A1 (de) 1996-06-26
DK0718295T3 (da) 1999-01-11
EP0718295B1 (de) 1998-04-22
ITBO940562A1 (it) 1996-06-21
ES2115308T3 (es) 1998-06-16
GR3026702T3 (en) 1998-07-31
JPH08231535A (ja) 1996-09-10
DE69502168T2 (de) 1998-08-13
JP2820652B2 (ja) 1998-11-05
ATE165354T1 (de) 1998-05-15
IT1274355B (it) 1997-07-17

Similar Documents

Publication Publication Date Title
CY1106870T1 (el) Σταθεροποιηση ραπαμυκινης ή παραγωγων ραπαμυκινης
EA200500249A1 (ru) Применение соединений для лечения заболевания, опосредованного vcam-1
ECSP024384A (es) INHIBIDORES DE HMG - CoA REDUCTASA Y METODO
CA2583037A1 (en) Pouched compositions comprising peracid
EA200000888A1 (ru) Производные желчных кислот
IS2125B (is) Frumuviðloðunar-bælandi bólgu-eyðandi og ónæmisbælandi efnasambönd
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
PT1235799E (pt) Forma polimorfica de atorvastatina-calcio
ATE485290T1 (de) Platelet adp rezeptor inhibitoren
DE60015388D1 (de) Zusammensetzung daraus hergestellte gegenstände
ATE375347T1 (de) Pyrazolopyrimidinonderivate mit pde7-hemmender wirkung
DE60324544D1 (de) Muskarin antagonisten
DK0831721T3 (da) Dej- og paneringsbelagte levnedsmiddelsammensætninger ved anvendelse af calciumpectiner
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE450812T1 (de) Antihypercholesterolemika.
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
DE69717101D1 (de) VERWENDUNG VON alpha-ALKYLGLUCOSIDEN UND DEREN ESTERN ALS ANTIMIKROBIELLE EMULGATOREN
DE69502168D1 (de) Lactone mit antioxidativer und hypolipidaemischer Wirkung zur Behandlung von Atherosklerose
ES2108698T3 (es) Liposomas exentos de sustancias activas, para el tratamiento de aterosclerosis.
EA200300066A1 (ru) Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
ID24891A (id) Proses untuk stabilisasi minyak dari bahan-bahan tanaman
ES2168189B1 (es) Derivados de piperazinona
IT1266570B1 (it) Derivati della propanammide n-eteroaril sostituiti utili nel trattamento delle malattie cardiovascolari
ATE270284T1 (de) Cholesterin esterase inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee